Universal-Beteiligungs- und Servicegesellschaft’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$158M Sell
1,271,365
-61,749
-5% -$8.14M 0.24% 79
2026
Q1
$183M Buy
1,333,114
+19,741
+2% +$2.76M 0.31% 56
2025
Q4
$159M Buy
1,313,373
+126,909
+11% +$15.4M 0.26% 71
2025
Q3
$132M Sell
1,186,464
-55,708
-4% -$6.33M 0.22% 89
2025
Q2
$138M Buy
1,242,172
+44,527
+4% +$4.74M 0.24% 80
2025
Q1
$134M Buy
1,197,645
+67,389
+6% +$6.95M 0.27% 77
2024
Q4
$104M Buy
+1,130,256
New +$102M 0.21% 95

Other funds holding GILD

Universal-Beteiligungs- und Servicegesellschaft's GILD Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Gilead Sciences (GILD) stake by 4.6% in Q2 2026, selling an estimated $8.14M and leaving 1,271,365 shares worth $158M. The position accounts for 0.24% of the portfolio, ranked #79.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $183M in Q1 2026. 2,277 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 1,271,365 shares of Gilead Sciences worth $158M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 61,749 Gilead Sciences shares in Q2 2026, an estimated $8.14M.
  • Gilead Sciences made up 0.24% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #79 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Gilead Sciences position peaked at $183M in Q1 2026.
  • 2,277 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.